We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Single Hardware Solution Utilizes Multiple Diagnostics Technologies

By LabMedica International staff writers
Posted on 09 Sep 2010
A single hardware solution utilizes multiple diagnostics technologies such as enzyme immunoassay (EIA), chemiluminescence, and multiplexing.

Called the ThunderBolt platform, the inaugural product is an EIA processor, with a completely open software design capable of programming virtually any EIA test.

These tests are widely used to detect and quantify substances such as peptides, proteins, antibodies, and hormones, and to diagnose diseases and conditions including infections, cancer, metabolic disorders, allergies, and autoimmune diseases.

In a single, easily configured run, the flexible ThunderBolt EIA processor can process multiple microtiter plates, while also running up to eight different simultaneous assays. More...
With an onboard reader, the fully automated processor offers a true walkaway solution for labs of any size.

The compact design takes up less than half the workspace of similar EIA automated processors on the market. Cost-effective operation makes the platform suitable for larger clinical laboratories, while it also provides the customizable capabilities needed in hospital or research laboratories.

Gold Standard Diagnostics, Corp. (Davis, CA, USA), a provider of laboratory diagnostics solutions, introduced the ThunderBolt platform at the 2010 Clinical Lab Expo of the American Association for Clinical Chemistry (AACC), which was held at the Anaheim Convention Center (CA, USA) on July 25-29, 2010.

"The ThunderBolt platform represents a true innovation in automated diagnostics instrumentation and is the culmination of nearly 20 years of feedback from laboratory customers around the world,” says John Griffiths, president and CEO of Gold Standard Diagnostics. "By understanding what customers really need, we have been able to build a product that's the right blend of power, flexibility, and ease of use, all at a competitive price.”

GSD provides products, services, and consulting to the diagnostic and medical communities. The company has been creating and cost-effective diagnostics solutions for clinical and hospital laboratories since 2006.

Related Links:
Gold Standard Diagnostics, Corp.
American Association for Clinical Chemistry



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PSA Assay
CanAg PSA EIA
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.